healthday on MSN5 天
SGLT-2 Inhibitors Beneficial for Patients With Nephrolithiasis
For patients with nephrolithiasis, sodium-glucose cotransporter-2 (SGLT-2) inhibitor use is associated with a reducti ...
Drugs like Ozempic may help lower 2nd stroke, heart attack risk
GLP-1 agonist drugs like Ozempic, and SLGT2 inhibitor drugs like Jardiance have been linked with a lower risk of a second ...
Renal & Urology News2 天
SGLT2 Inhibitors Might Lower Stone Risk Better Than Other Type 2 Diabetes Drugs
SGLT2 inhibitors may help reduce the risk of nephrolithiasis in patients with type 2 diabetes, including those with co-existing gout. Recent large-scale studies support that sodium-glucose ...
HealthDay on MSN5 天
AHA: GLP-1 RA, SGLT-2i Use Can Lower Risk for MI, Recurrent Stroke in Stroke Survivors
For patients with ischemic stroke, sodium-glucose cotransporter-2 inhibitors (SGLT-2is) and glucagon-like peptide-1 receptor ...
GLP-1 RA use tied to lower rate of venous thromboembolism in diabetes
For patients with type 2 diabetes mellitus (T2DM), glucagon-like peptide 1 receptor agonist (GLP-1 RA) use is associated with ...
Weight-loss drugs can help stroke survivors prevent recurrence
The weight-loss drug Ozempic can help reduce stroke patients' risk of a heart attack or death, a new study says.
clinicaladvisor.com6 天
SGLT-2 Inhibitors Beneficial for Patients With Nephrolithiasis
Reduction seen in recurrent nephrolithiasis events for those receiving SGLT-2 inhibitors vs GLP-1 RAs, DPP-4 inhibitors. HealthDay News — For patients with nephrolithiasis, sodium-glucose ...
BioPharma Dive4 天
Metsera raises $215M to accelerate obesity drug plans
With promising Phase 1 results in hand, Metsera hopes to develop a longer-lasting GLP-1 injection along with other types of ...
Daily5 天
GLP-1, SGLT2 medications may lower risk of future MI and repeat stroke among stroke ...
GLP-1 receptor agonists and SGLT2 inhibitors, two classes of medications most commonly prescribed to treat Type 2 diabetes or ...